Skip to content

Category: Biotechnology

LTR Pharma’s SPONTAN® Treatment for Erectile Dysfunction Demonstrates 100% Patient Satisfaction in Post-Prostatectomy Study

By API User

25 August 2025 – Sydney, Australia | LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) today announced highly encouraging results from a case series that is evaluating the efficacy of its intranasal erectile dysfunction therapy, SPONTAN®, in men recovering from radical prostatectomy. The results, presented at the 25th Asia-Pacific Prostate Cancer Conference (APCC) in … Continued

LTR Pharma Announces SPONTAN® Achieves 18-Month Shelf Life

By API User

22 August 2025 | Sydney, Australia – LTR Pharma Limited (ASX:LTP) today announced that SPONTAN® has achieved an 18-month shelf life under international pharmaceutical stability standards, a key milestone that strengthens the product’s commercial potential in the global erectile dysfunction market, forecast to reach US$6.0 billion by 2028. This achievement demonstrates the robustness of SPONTAN’s formulation, … Continued

Velos to accelerate medical innovation in the Monash Technology Precinct

By API User

Key points $17.5 million from the Victorian Government has enabled the Monash Velos Accelerator  Velos will focus on cardiovascular, kidney and metabolic disease It will foster collaboration and commercialisation of medical innovation A new Monash Technology Precinct accelerator focussing on cardiovascular, kidney and metabolic diseases will help transform medical innovation ideas into reality. Monash Velos … Continued

Velos to accelerate medical innovation in the Monash Technology Precinct

By API User

Key points $17.5 million from the Victorian Government has enabled the Monash Velos Accelerator  Velos will focus on cardiovascular, kidney and metabolic disease It will foster collaboration and commercialisation of medical innovation A new Monash Technology Precinct accelerator focussing on cardiovascular, kidney and metabolic diseases will help transform medical innovation ideas into reality. Monash Velos … Continued

LTR Pharma Clinical Study Published in Leading European Journal Validates Rapid Onset for Nasal Erectile Dysfunction Therapy

By API User

20 August 2025 | Sydney, Australia – LTR Pharma Limited (ASX:LTP) is pleased to announce a peer-reviewed publication of clinical data from its Phase I pharmacokinetic study of SPONTAN®, the Company’s flagship intranasal formulation for erectile dysfunction (ED). The data has been published in the European Journal of Pharmaceutical Sciences, which is a highly regarded … Continued

Peter Beattie AC appointed Brandon BioCatalyst Chair

By API User

Melbourne, Australia Tuesday, 19 August 2025: Brandon BioCatalyst, a collaboration of more than 50 of Australia and New Zealand’s leading medical research institutes, hospitals and universities, today announced new board appointments to continue the scaling of Australian medical research into globally competitive biotech companies.   The board transition sees the appointment of long-standing director and … Continued

Cartherics unveils state-of-the-art cleanroom facility for cell therapy manufacturing

By API User

Melbourne, Australia, 6 August 2025 –  Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing off-the-shelf immune stem cell therapies focusing on high-impact women’s diseases, with lead programs in ovarian cancer and endometriosis, today unveiled its new, state-of-the-art cleanroom facility for clinical-scale manufacturing of cell therapy products. The facility was officially opened by the … Continued

Biolog Enters the European Diagnostic Market, Bringing 45 Years of Anaerobic Culture Excellence

By API User

Biolog, a leading provider of microbial identification and phenotypic characterization tools and services, announced today that both its anaerobic media and anaerobic chambers have received CE marking, clearing the way for broader international use HAYWARD, CALIFORNIA / ACCESS Newswire / July 29, 2025 / Biolog, a leading provider of microbial identification and phenotypic characterization tools … Continued

EcoPHA Biotech Unveils World-First PHA Breakthrough at FEMS MICRO 2025 in Milan

By API User

EcoPHA Biotech Unveils World-First PHA Breakthrough at FEMS MICRO 2025Australian innovation uses Pongamia oil to produce scalable, marine-safe bioplastics Milan / Sydney – 29 July 2025 –Australian biotech leader EcoPHA has unveiled a major scientific breakthrough at FEMS MICRO 2025, one of the world’s foremost conferences in microbiology and environmental innovation, held this week in Milan, … Continued